Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by investclubon Aug 14, 2019 5:17pm
140 Views
Post# 30029116

Big buys

Big buys






Barclay buying all day


 - V  
10.0 0.285 · 0.29 19.0 0.29 -0.005 -1.7 2,076.9 595 131 0.29  0.29  0.28 0.60  0.25 16:15:02 Aug 01 15 min RT 2¢
TSX-V - V 10.0 0.285 · 0.29 19.0 0.29 -0.005 -1.7 1,880.9 539 95 0.29  0.29  0.28 0.60  0.25 16:15:02   15 min
Alpha - A   0.28 -0.015 -5.1 21.5 6 3 0.29  0.29  0.28   15:26:39   15 min
Chi-X - X   0.28 -0.015 -5.1 95.5 27 7 0.285  0.285  0.28   15:31:46   15 min
CX2 - H   0.29 -0.005 -1.7 28.0 8 9 0.285  0.29  0.28   15:38:34   15 min
Omega - O   0.285 -0.01 -3.4 3.0 1 2 0.285  0.285  0.285   14:18:02   15 min
TriAct - M   0.295     1.0 0 4        Aug 13 14:15:20   15 min
NEO ATS - U   0.285 -0.01 -3.4 47.0 13 11 0.29  0.29  0.285   14:41:11   15 min

 

Recent Trades - Last 10 of 131
Time ET Ex Price Change Volume Buyer Seller Markers
16:15:02 V 0.29 -0.005 5,000 99 Jitney 7 TD Sec K
16:15:02 V 0.29 -0.005 10,000 99 Jitney 7 TD Sec K
15:59:59 V 0.29 -0.005 1,500 79 CIBC 7 TD Sec K
15:59:59 V 0.29 -0.005 6,000 79 CIBC 7 TD Sec K
15:59:15 V 0.29 -0.005 58,500 90 Barclays 1 Anonymous K
15:59:15 V 0.29 -0.005 1,000 90 Barclays 1 Anonymous K
15:59:15 V 0.29 -0.005 410,000 90 Barclays 7 TD Sec K
15:57:49 V 0.29 -0.005 300 7 TD Sec 36 Latimer  
15:57:49 V 0.29 -0.005 8,500 7 TD Sec 7 TD Sec K
15:57:49 V 0.29 -0.005 10,000 7 TD Sec 7 TD Sec K
 

 

 

 

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins News ReleasesIn The NewsOther
Date ET Symbol Price Type Headline
2019-08-01 09:40 C:TLT 0.31 News Release Theralase Technologies prices $15-million unit offering
2019-07-31 09:07 C:TLT 0.31 News Release Theralase talks up phase Ib NMIBC study results
2019-07-29 07:46 C:TLT 0.335 News Release Theralase enrolls first patient in phase II NMIBC study
2019-07-24 07:46 C:TLT 0.375 News Release Theralase hires trial outfit to provide study sites

 

 
 

 

 

 

Bullboard Posts